172 related articles for article (PubMed ID: 31387952)
21. Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial.
Winther SB; Liposits G; Skuladottir H; Hofsli E; Shah CH; Poulsen LØ; Ryg J; Osterlund P; Berglund Å; Qvortrup C; Glimelius B; Sorbye H; Pfeiffer P
Lancet Gastroenterol Hepatol; 2019 May; 4(5):376-388. PubMed ID: 30852136
[TBL] [Abstract][Full Text] [Related]
22. Utilisation of Adjuvant Chemotherapy and 5-Year Survival Analysis of Prospectively Recorded Cohort Data for Older Adults Versus Younger Adults with Resected Primary Colon Cancer.
Shafiei M; Beale P; Blinman P
J Gastrointest Cancer; 2020 Sep; 51(3):988-997. PubMed ID: 31811472
[TBL] [Abstract][Full Text] [Related]
23. Frailty screening for predicting rapid functional decline, rapid progressive disease, and shorter overall survival in older patients with gastrointestinal cancer receiving palliative chemotherapy - a prospective, clinical study.
Jespersen E; Winther SB; Minet LR; Möller S; Pfeiffer P
J Geriatr Oncol; 2021 May; 12(4):578-584. PubMed ID: 33830020
[TBL] [Abstract][Full Text] [Related]
24. Associations and prognostic implications of Eastern Cooperative Oncology Group performance status and tumoral LINE-1 methylation status in stage III colon cancer patients.
Chen D; Wen X; Song YS; Rhee YY; Lee TH; Cho NY; Han SW; Kim TY; Kang GH
Clin Epigenetics; 2016; 8():36. PubMed ID: 27051466
[TBL] [Abstract][Full Text] [Related]
25. Low lean mass and chemotherapy toxicity risk in the elderly: the Fraction study protocol.
Steinmeyer Z; Gérard S; Filleron T; Lozano S; Brechemier D; Abellan Van Kan G; Mourey L; Cristol-Dalstein L; De Decker L; Rolland Y; Balardy L
BMC Cancer; 2019 Nov; 19(1):1153. PubMed ID: 31775667
[TBL] [Abstract][Full Text] [Related]
26. A retrospective evaluation of geriatric patients with gastric cancer receiving systemic chemotherapy.
Tatli AM; Urakci Z; Tastekin D; Koca D; Goksu SS; Uyeturk U; Kaplan MA; Coskun HS
J Cancer Res Ther; 2020 Dec; 16(Supplement):S138-S143. PubMed ID: 33380668
[TBL] [Abstract][Full Text] [Related]
27. Predicting the Risks of Aggressive-Intent Chemotherapy Toxicity in Older Patients With Lymphoma: A Prospective Observational Pilot Study.
Dhir V; Maganti M; Rozenberg D; Kukreti V; Kuruvilla J; Crump M; Prica A
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e792-e803. PubMed ID: 35650009
[TBL] [Abstract][Full Text] [Related]
28. Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients.
Aparicio T; Jouve JL; Teillet L; Gargot D; Subtil F; Le Brun-Ly V; Cretin J; Locher C; Bouché O; Breysacher G; Charneau J; Seitz JF; Gasmi M; Stefani L; Ramdani M; Lecomte T; Mitry E
J Clin Oncol; 2013 Apr; 31(11):1464-70. PubMed ID: 23460711
[TBL] [Abstract][Full Text] [Related]
29. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.
Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH
Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824
[TBL] [Abstract][Full Text] [Related]
30. Utility of the Geriatric 8 for the Prediction of Therapy-Related Toxicity in Older Adults with Diffuse Large B-Cell Lymphoma.
Oiwa K; Fujita K; Lee S; Morishita T; Tsukasaki H; Negoro E; Ueda T; Yamauchi T
Oncologist; 2021 Mar; 26(3):215-223. PubMed ID: 33320984
[TBL] [Abstract][Full Text] [Related]
31. Predicting early death in older adults with cancer.
Boulahssass R; Gonfrier S; Ferrero JM; Sanchez M; Mari V; Moranne O; Rambaud C; Auben F; Hannoun Levi JM; Bereder JM; Bereder I; Baque P; Turpin JM; Frin AC; Ouvrier D; Borchiellini D; Largillier R; Sacco G; Delotte J; Arlaud C; Benchimol D; Durand M; Evesque L; Mahamat A; Poissonnet G; Mouroux J; Barriere J; Benizri E; Piche T; Guigay J; Francois E; Guerin O
Eur J Cancer; 2018 Sep; 100():65-74. PubMed ID: 30014882
[TBL] [Abstract][Full Text] [Related]
32. Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database.
Cheung WY; Renfro LA; Kerr D; de Gramont A; Saltz LB; Grothey A; Alberts SR; Andre T; Guthrie KA; Labianca R; Francini G; Seitz JF; O'Callaghan C; Twelves C; Van Cutsem E; Haller DG; Yothers G; Sargent DJ
J Clin Oncol; 2016 Apr; 34(11):1182-9. PubMed ID: 26858337
[TBL] [Abstract][Full Text] [Related]
33. Functional status in older patients with cancer and a frailty risk profile: A multicenter observational study.
Meert G; Kenis C; Milisen K; Debruyne PR; De Groof I; Focan C; Cornélis F; Verschaeve V; Bachmann C; Bron D; Den Bulck HV; Schrijvers D; Langenaeken C; Specenier P; Jerusalem G; Praet JP; Lobelle JP; Flamaing J; Wildiers H; Decoster L
J Geriatr Oncol; 2022 Nov; 13(8):1162-1171. PubMed ID: 36085275
[TBL] [Abstract][Full Text] [Related]
34. Prediction of hospital admissions and grade 3-4 toxicities in cancer patients 70 years old and older receiving chemotherapy.
Reed M; Patrick C; Quevillon T; Walde N; Voutsadakis IA
Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13144. PubMed ID: 31429128
[TBL] [Abstract][Full Text] [Related]
35. G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer.
Shah M; Noronha V; Ramaswamy A; Gattani S; Mokal S; Joshi A; Patil V; Menon N; Banavali S; Badwe R; Prabhash K
J Geriatr Oncol; 2022 Jun; 13(5):720-730. PubMed ID: 35283049
[TBL] [Abstract][Full Text] [Related]
36. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
[TBL] [Abstract][Full Text] [Related]
37. ECOG performance score 0 versus 1: impact on efficacy and safety of first-line 5-FU-based chemotherapy among patients with metastatic colorectal cancer included in five randomized trials.
Abdel-Rahman O
Int J Colorectal Dis; 2019 Dec; 34(12):2143-2150. PubMed ID: 31732876
[TBL] [Abstract][Full Text] [Related]
38. Grip strength as a frailty diagnostic component in geriatric inpatients.
Dudzińska-Griszek J; Szuster K; Szewieczek J
Clin Interv Aging; 2017; 12():1151-1157. PubMed ID: 28794619
[TBL] [Abstract][Full Text] [Related]
39. Predictors and effects of toxicity experienced by older adults with cancer receiving systemic therapy in a randomized clinical trial of geriatric assessment.
Mariano C; Brennenstuhl S; Alibhai S; Tejero I; Strohschein F; Monette J; Szumacher E; Hsu T; Puts M
J Geriatr Oncol; 2023 Sep; 14(7):101584. PubMed ID: 37429107
[TBL] [Abstract][Full Text] [Related]
40. CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer.
Won E; Hurria A; Feng T; Mohile S; Owusu C; Klepin HD; Gross CP; Lichtman SM; Gajra A; Tew WP;
Int J Gynecol Cancer; 2013 Jul; 23(6):1022-8. PubMed ID: 23765208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
